Skip to main content
. 2023 Jan 12;47(2):220–231. doi: 10.4093/dmj.2021.0327

Fig. 2.

Fig. 2.

Risks of all-cause and cardiovascular death according to the presence of (A, B) nonalcoholic fatty liver disease (NAFLD) or (C, D) metabolic dysfunction-associated fatty liver disease (MAFLD). (A) Hazard ratio (HR) of all-cause death in NAFLD patients; (B) HR of cardiovascular death in NAFLD patients; (C) HR of all-cause death in MAFLD patients; (D) HR of cardiovascular death in MAFLD patients. CI, confidence interval.